share_log

Earnings Call Summary | American Shared Hospital Services(AMS.US) Q4 2023 Earnings Conference

Earnings Call Summary | American Shared Hospital Services(AMS.US) Q4 2023 Earnings Conference

業績電話會議摘要 | 美國共享醫院服務 (AMS.US) 2023 年第四季度業績會議
moomoo AI ·  03/28 14:44  · 電話會議

The following is a summary of the American Shared Hospital Services (AMS) Q4 2023 Earnings Call Transcript:

以下是美國共享醫院服務(AMS)2023年第四季度業績電話會議記錄摘要:

Financial Performance:

財務業績:

  • American Shared Hospital Services reported Q4 revenue of $5.7 million, a YoY increase of 13%.

  • Gross margin for the same period was $2.8 million or 49% of revenue, a rise of 24% YoY.

  • The EPS for the company stood at $0.06, in spite of additional costs and asset reserves.

  • For the entire year of 2023, the revenue increased by 8% reaching $21.3 million, and gross margin was $9.3 million, a rise of 11.5%.

  • The cash and equivalent at year end stood at $13.8 million, approximately equal to $2.19 per share.

  • 美國共享醫院服務報告第四季度收入爲570萬美元,同比增長13%。

  • 同期毛利率爲280萬美元,佔收入的49%,同比增長24%。

  • 儘管增加了成本和資產儲備,但該公司的每股收益仍爲0.06美元。

  • 2023年全年,收入增長了8%,達到2,130萬美元,毛利率爲930萬美元,增長了11.5%。

  • 截至年底,現金及等價物爲1,380萬美元,約等於每股2.19美元。

Business Progress:

業務進展:

  • AMS ended the year with a robust sales pipeline, due to improvements in the sales team, expanding financial solutions and closer integration with strategic OEMs.

  • The company executed equipment upgrades in Ecuador, driving volume growth.

  • The company is planning to open an international center in Puebla, Mexico in Q2 2024 and expand business models to include development of their own majority-owned Proton Beam and radiation oncology centers in the US.

  • AMS acquired a majority interest in three radiation therapy cancer centers in Rhode Island, signaling its entry into direct patient services in the US.

  • The company expects further growth from international business due to additional treatment capacities in Ecuador, the new center in Puebla, and projected closing of the Rhode Island acquisition.

  • 由於銷售團隊的改善、財務解決方案的擴大以及與戰略OEM的更緊密整合,AMS在年底以強勁的銷售渠道結束。

  • 該公司在厄瓜多爾進行了設備升級,推動了銷量增長。

  • 該公司計劃於2024年第二季度在墨西哥普埃布拉開設一個國際中心,並擴大商業模式,包括在美國開發自己的控股權質子束和放射腫瘤學中心。

  • AMS收購了羅德島州三個放射治療癌症中心的多數股權,這標誌着其進入美國的直接患者服務領域。

  • 該公司預計,由於厄瓜多爾的治療能力增加,普埃布拉的新中心以及預計將完成對羅德島的收購,國際業務將進一步增長。

Tips: This article is generated by AI. The accuracy of the content can not be fully guaranteed. For more comprehensive details, please refer to the IR website. The article is only for investors' reference without any guidance or recommendation suggestions.

提示:本文由 AI 生成。無法完全保證內容的準確性。欲了解更多詳情,請訪問投資者關係網站。本文僅供投資者參考,不構成任何投資建議。

声明:本內容僅用作提供資訊及教育之目的,不構成對任何特定投資或投資策略的推薦或認可。 更多信息
    搶先評論